Interplay of gut microbiota and oxidative stress: Perspective on neurodegeneration and neuroprotection

Shandilya, Shruti; Kumar, Sandeep; Jha, Niraj Kumar; Kesari, Kavindra Kumar; Ruokolainen, Janne

doi:10.1016/j.jare.2021.09.005

Cited by 131 publications

(104 citation statements)

References 319 publications

(300 reference statements)

Supporting

Mentioning

101

Contrasting

Unclassified

Order By: Relevance

“…Thus, therapies targeting the suppression of oxidative stress may delay or reduce the severity of PD (127). It is increasingly accepted that oxidative stress may be aggravated by concomitant PD-associated gut dysbiosis (128). Generally, healthy gut microbiota have an immense antioxidative and anti-inflammatory role, while gut dysbiosis can manifest low-grade inflammation, cellular degeneration, and an imbalance of cellular energy followed by an increasing oxidative stress state (129).…”

Section: Oxidative Stressmentioning

confidence: 99%

Gut Microbiota: A Novel Therapeutic Target for Parkinson’s Disease

Zhu

Liu

et al. 2022

Front. Immunol.

View full text Add to dashboard Cite

Parkinson’s disease (PD) is the second most common neurodegenerative disease characterized by motor dysfunction. Growing evidence has demonstrated that gut dysbiosis is involved in the occurrence, development and progression of PD. Numerous clinical trials have identified the characteristics of the changed gut microbiota profiles, and preclinical studies in PD animal models have indicated that gut dysbiosis can influence the progression and onset of PD via increasing intestinal permeability, aggravating neuroinflammation, aggregating abnormal levels of α-synuclein fibrils, increasing oxidative stress, and decreasing neurotransmitter production. The gut microbiota can be considered promising diagnostic and therapeutic targets for PD, which can be regulated by probiotics, psychobiotics, prebiotics, synbiotics, postbiotics, fecal microbiota transplantation, diet modifications, and Chinese medicine. This review summarizes the recent studies in PD-associated gut microbiota profiles and functions, the potential roles, and mechanisms of gut microbiota in PD, and gut microbiota-targeted interventions for PD. Deciphering the underlying roles and mechanisms of the PD-associated gut microbiota will help interpret the pathogenesis of PD from new perspectives and elucidate novel therapeutic strategies for PD.

show abstract

Section: Oxidative Stressmentioning

confidence: 99%

Gut Microbiota: A Novel Therapeutic Target for Parkinson’s Disease

Zhu

Liu

et al. 2022

Front. Immunol.

View full text Add to dashboard Cite

show abstract

“…Fermented food, containing potentially probiotic microorganisms [ 42 ], may reverse these abnormalities. Probiotics and healthy gut microbes exhibit in vivo antioxidant properties, attenuating oxidative stress [ 43 ], present anti-inflammatory properties [ 43 , 44 , 45 ], may restore serotonergic neurotransmission [ 45 ] and normalize the function of the HPA axis [ 44 ], and possibly enhance BDNF expression in the brain [ 46 ]. All these mechanisms may contribute to the antidepressant action of probiotics [ 45 , 47 ].…”

Section: Discussionmentioning

confidence: 99%

Who Benefits from Fermented Food Consumption? A Comparative Analysis between Psychiatrically Ill and Psychiatrically Healthy Medical Students

Karbownik

Mokros

Kowalczyk

2022

IJERPH

View full text Add to dashboard Cite

Probiotic therapies and fermented food diets hold promise for improving mental health. Although in this regard psychiatric patients appear to benefit more than healthy individuals, no research has been performed to directly evaluate this hypothesis. The present study examined a cohort of medical students facing a stressful event, and some of the students reported suffering from chronic psychiatric diseases. The amount of fermented food consumption was calculated with the use of seven-day dietary records, while depressive and anxiety symptoms were assessed with the use of the Patient Health Questionnaire-9 and Generalized Anxiety Disorder-7, respectively. In psychiatrically healthy medical students under psychological stress (n = 372), higher fermented food consumption was associated with more depressive and anxiety symptoms. In contrast, psychiatrically ill medical students (n = 25, 6.3% of all the participants) were found to present a negative association between the amount of fermented food consumed and the severity of depressive symptoms (adjusted β −0.52, 95% CI −0.85 to −0.19, p = 0.0042); however, this relationship was insignificant for anxiety symptoms (adjusted β −0.22, 95% CI −0.59 to 0.15, p = 0.22). A significant interaction was found between the consumption of fermented food and psychiatric diagnosis in predicting depressive symptoms (p = 0.0001), and a borderline significant interaction for anxiety symptoms (p = 0.053). In conclusion, psychiatrically ill people, but not healthy ones, may benefit from fermented food consumption in terms of alleviation of depressive symptoms. Our findings require cautious interpretation and further investigation.

show abstract

“…bulgaricus), Lactobacillus acidophilus and inactivated lactobacillus [14,27]. This raises the importance of further study on probiotics that target this mechanism as a potential method to treat stroke patients in the future [59].…”

Section: Probiotic and Oxidative Stressmentioning

confidence: 99%

Probiotic as a Potential Gut Microbiome Modifier for Stroke Treatment: A Systematic Scoping Review of In Vitro and In Vivo Studies

et al. 2022

View full text Add to dashboard Cite

Background: Pharmacologic and non-pharmacologic treatments for stroke are essential but can be costly or harmful, whereas probiotics are a promising alternative. This scoping review aimed to synthesize the in vitro and in vivo evidence of probiotics on stroke-related neurological, biochemical, and histochemical outcomes. Methods: A systematic review was conducted in PubMed, Embase, and Cochrane Central Register of Clinical Trials (CENTRAL) up to 7 May 2021. Titles and abstracts were screened and assessed by two independent reviewers. The initial screening criteria aimed to include studies using probiotics, prebiotics, and symbiotics both in vitro and in vivo for the prevention and/or treatment of stroke. Results: Of 6293 articles, 4990 passed the initial screen after excluding duplication articles, of which 36 theme-related full texts were assessed and 13 were included in this review. No in vitro studies passed the criteria to be included in this review. Probiotics can ameliorate neurological deficits and show their anti-inflammation and anti-oxidative properties. Decreased loss of cerebral volume and inhibition of neuronal apoptosis were revealed in histopathological evidence. Conclusions: There are potential cognitive benefits of probiotic supplementation, especially among animal models, on decreasing cerebral volume, increasing neurological score, and decreasing the inflammatory response. However, further investigation is needed to validate these conclusions in various populations.

show abstract

Interplay of gut microbiota and oxidative stress: Perspective on neurodegeneration and neuroprotection

Cited by 131 publications

References 319 publications

Gut Microbiota: A Novel Therapeutic Target for Parkinson’s Disease

Gut Microbiota: A Novel Therapeutic Target for Parkinson’s Disease

Who Benefits from Fermented Food Consumption? A Comparative Analysis between Psychiatrically Ill and Psychiatrically Healthy Medical Students

Probiotic as a Potential Gut Microbiome Modifier for Stroke Treatment: A Systematic Scoping Review of In Vitro and In Vivo Studies

Contact Info

Product

Resources

About